🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Docetaxel, cyclophosphamide

Found 0 matching trials

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells

PHASE2

This phase II trial studies the efficacy of trastuzumab treatment in breast...

Status

Terminated

Location

Washington University School of Medicine

Start Date

2013-12-19

Trial ID

NCT01779050

Treatments Being Tested

Doxorubicin Trastuzumab Cyclophosphamide Paclitaxel Epirubicin Docetaxel Carboplatin Fluorouracil

Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer

PHASE2

This phase II trial studies how well trastuzumab and pertuzumab or bevacizu...

Status

Completed

Location

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Start Date

2013-09-24

Trial ID

NCT01959490

Treatments Being Tested

trastuzumab Pertuzumab docetaxel carboplatin doxorubicin cyclophosphamide paclitaxel Bevacizumab

Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

PHASE1

Multi-center, non randomised, open label, non controlled pilot study. Evalu...

Status

Unknown

Location

Institut Salah Azaiz

Start Date

2011-03

Trial ID

NCT01880385

Treatments Being Tested

Bevacizumab Cyclophosphamide epirubicin hydrochloride fluorouracil Docetaxel Trastuzumab

Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients

PHASE4

This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...

Status

Unknown

Location

Cancer institute

Start Date

2016-12

Trial ID

NCT03123770

Treatments Being Tested

Pegylated liposomal doxorubicin Cyclophosphamide Epirubicin Docetaxel

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

PHASE3

This is a global Phase III, two-arm, open-label, multicenter, randomized st...

Status

Completed

Location

Maryland Oncology Hematology

Start Date

2018-06-14

Trial ID

NCT03493854

Treatments Being Tested

Cyclophosphamide Doxorubicin Docetaxel Paclitaxel Pertuzumab IV FDC of Pertuzumab and Trastuzumab SC Trastuzumab IV Trastuzumab SC Surgery Post-operative Radiotherapy Hormone Therapy

Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer

PHASE2

This is an exploratory interventional study that initiates chemotherapy wit...

Status

Unknown

Location

National Cancer Center

Start Date

2017-05-08

Trial ID

NCT03497702

Treatments Being Tested

Doxorubicin Cyclophosphamide Docetaxel Letrozole leuprorelin

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

PHASE2

This multicenter, non-randomized, open-label, phase 2 study is designed to ...

Status

Completed

Location

University of South Alabama; Mitchell Cancer Institute

Start Date

2014-07-14

Trial ID

NCT02132949

Treatments Being Tested

5-Fluorouracil Cyclophosphamide Docetaxel Doxorubicin Epirubicin Paclitaxel Pertuzumab Trastuzumab

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

PHASE3

The main purpose of this study is to learn if adding bevacizumab to standar...

Status

Completed

Location

Birmingham Hematology and Oncology

Start Date

2009-05

Trial ID

NCT00887536

Treatments Being Tested

bevacizumab docetaxel doxorubicin cyclophosphamide pegfilgrastim

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

N/A

RATIONALE: Gathering information over time from laboratory tests, imaging s...

Status

Completed

Location

UCSF Helen Diller Family Comprehensive Cancer Center

Start Date

2007-05

Trial ID

NCT00755313

Treatments Being Tested

trastuzumab aromatase inhibition therapy carboplatin cyclophosphamide docetaxel doxorubicin hydrochloride metabolic assessment questionnaire administration study of socioeconomic and demographic variables cognitive assessment positron emission tomography fludeoxyglucose F 18

Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction

PHASE3

The main clinical goal of NAC is to down-stage the primary tumor for BCS,ye...

Status

Unknown

Location

Shandong Cancer Hospital

Start Date

2008-08

Trial ID

NCT01917578

Treatments Being Tested

Ultrasound CNB BCS, Modified Radical Mastectomy Pathologic Large Tissue Selected Table Leica TP1020 Pathologic Large Tissue Embedded Table Leica SM2000 R HE Stain CX22 Epson V600 MRI Three-Dimensional Reconstruction Mammography TAC,TC,TA,CAF,CEF AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF

Previous Next